TWST
Twist Bioscience Corp
NASDAQ: TWST · HEALTHCARE · BIOTECHNOLOGY
$127.22
+0.29% today
Updated 2026-09-11
Market cap
$8.03B
P/E ratio
—
P/S ratio
19.52x
EPS (TTM)
$-2.23
Dividend yield
—
52W range
$23 – $155
Volume
1.6M
Twist Bioscience Corp (TWST) Financial Forecast & Price Target 2030
Revenue-driven projection model with historical context.
Price target summary
Current price
$127.22
12-Month target
—
2030 Target
—
Intrinsic (DCF)
$122.44
Financial forecast
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | $0.1B | $0.2B | $0.2B | $0.3B | $0.4B |
| EPS | — | — | — | — | — |
CAGR applied: — (capped 20%) · P/E: 25.00x (capped 25x) · Margin: -31.70%
Methodology
CAGR-based projection model. Research-backed estimates are being generated — check back soon for analyst consensus and management guidance.